Induced Anti-Non Gal Antibodies in Human Xenograft Recipients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Anti-non gal antibodies are produced in xenograft recipients against multiple xenogeneic antigens. Studies in monkeys transplanted with pig organs lacking α-gal epitopes have suggested that anti-non gal antibodies mediate acute and chronic rejection of xenografts. This overview describes studies of these antibodies in patients who received xenografts and includes (1) an ovarian carcinoma patient receiving three intraperitoneal infusions of mouse fibroblasts in a gene therapy study, (2) orthopedic patients with torn anterior cruciate ligament replaced by a ligament made of pig patellar tendon, and (3) diabetic patients receiving fetal pig islet cell clusters xenograft together with a kidney allograft. Anti-non gal antibodies were found to be continuously produced as long as the xenograft was present in the recipient and were directed against a large number of pig proteins. Monitoring the immune response in the recipient of mouse fibroblasts indicated that the production of anti-non gal antibodies is much slower than that of the anti-Gal antibody, suggesting that they are generated by multiple B-cell clones, each initially comprising relatively few cells. Potent immunosuppression to prevent allograft rejection does not fully inhibit the production of anti-non gal antibodies. Much of this antibody response seems to be due to the differences in amino acid sequences between pig and human orthologous proteins as a result of evolutionary mutations. Overcoming the anti-non gal antibody barrier will require immunosuppressive agents that preferentially inhibit this immune response while maintaining protection against pathogens, or alternatively development of methods for induction of immune tolerance to xenogeneic pig antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rates of DNA sequence evolution differ between taxonomic groups.
Britten, R. J. (1986) · Science · doi:10.1126/science.3082006 · Cited by 782 · cited 1×
“5% of the bases per million years (32).”
Cited by
Anti‐Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits
Galili, U. (2013) · Immunology · doi:10.1111/imm.12110 · Cited by 225
Self-citationDevalliere, J., Chen, Y., Dooley, K., Yarmush, M. L., & Uygun, B. E. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.046 · Cited by 84
Potential deleterious role of anti‐Neu5Gc antibodies in xenotransplantation
Salama, A., Evanno, G., Harb, J., & Soulillou, J. (2015) · Xenotransplantation · doi:10.1111/xen.12142 · Cited by 81
Characterization of immunogenic Neu5Gc in bioprosthetic heart valves
Reuven, E. M., Leviatan Ben‐Arye, S., Marshanski, T., Breimer, M. E., Yu, H., Fellah‐Hebia, I., Roussel, J., Costa, C., Galiñanes, M., Mañez, R., et al. (2016) · Xenotransplantation · doi:10.1111/xen.12260 · Cited by 80
Application of whole-organ tissue engineering in hepatology
Uygun, B. E., Yarmush, M. L., & Uygun, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.140 · Cited by 76
Metadata
- Authors
- Galili, U.
- Venue
- Transplantation
- Published
- 2012-01-15
- Volume
- 93
- Issue
- 1
- Pages
- 11-16
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1996031005
- Cited by
- 45
- References
- 1
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induced Anti-Non Gal Antibodies in Human Xenograft Recipients. https://app.cochat.ai/papers/10.1097/tp.0b013e31823be870
- The paper
- Galili, U. (2012). Induced Anti-Non Gal Antibodies in Human Xenograft Recipients. Transplantation. https://doi.org/10.1097/tp.0b013e31823be870
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.